1-(9-fluorenyl)methyl chloroformate and Osteoporosis

1-(9-fluorenyl)methyl chloroformate has been researched along with Osteoporosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Higashi, Y; Kasugai, S; Masamune, Y; Miya, K; Miyamoto, K; Morito, K; Nitta, Y; Nomura, M; Sakura, N; Sawanishi, H; Sekido, T; Yokogawa, K	1

Other Studies

1 other study(ies) available for 1-(9-fluorenyl)methyl chloroformate and Osteoporosis

Article	Year
Novel drug delivery system to bone using acidic oligopeptide: pharmacokinetic characteristics and pharmacological potential. Journal of drug targeting, 2001, Volume: 9, Issue:2 Topics: Acids; Animals; Bone and Bones; Chromatography, High Pressure Liquid; Drug Carriers; Drug Delivery Systems; Durapatite; Estradiol; Female; Fluorenes; Mice; Oligopeptides; Osteoporosis; Ovariectomy; Receptors, Estrogen	2001

Article

Year

Novel drug delivery system to bone using acidic oligopeptide: pharmacokinetic characteristics and pharmacological potential.

Journal of drug targeting, 2001, Volume: 9, Issue:2

Topics: Acids; Animals; Bone and Bones; Chromatography, High Pressure Liquid; Drug Carriers; Drug Delivery Systems; Durapatite; Estradiol; Female; Fluorenes; Mice; Oligopeptides; Osteoporosis; Ovariectomy; Receptors, Estrogen

2001